Chimeric antigen receptor therapy goes global
Interviewee/Contributor
Carl June
Organisation
University of Pennsylvania, Perelman School of Medicine
Research Directory
Cell and gene therapies pose new logistic challenges
Interviewee/ContributorSimon EllisonOrganisationWorld CourierBiotechs in Q2: For now, the trend is down
Interviewee/ContributorWilliam EllingtonOrganisationEvernow Publishing LtdCalliditas makes debut on Nasdaq Stockholm
Interviewee/ContributorRenée Aguiar-LucanderOrganisationCalliditas Therapeutics ABBuilding a culture of entrepreneurship in Nigeria
Interviewee/ContributorSelema AkuiyiboOrganisationSociety for Family Health NigeriaEU Commission proposes €100 billion for science
Interviewee/ContributorPeter CharlishOrganisationMedNousOrgans-on-chips enter the laboratories of big pharma
Interviewee/ContributorLorna Ewart and Geraldine HamiltonOrganisationAstraZeneca Plc and Emulate IncCombination therapy in oncology
Interviewee/ContributorGerben Moolhuizen and Kees MeliefOrganisationISA Pharmaceuticals BVASCO 2018: Oncology trials break new ground
Interviewee/ContributorBruno PagliaraThe myth of biotech self-determination
Interviewee/ContributorEdwin MosesOrganisationAblynx NV